Criterium Expands to Canada
CRITERIUM, Inc. Global CRO Expands Services to Canada
Criterium, Inc., a full-service CRO is pleased to announce its newest global office located in Toronto!
Get to know us and let us give you a brief overview of Criterium's expertise and our abilities to successfully manage your clinical trials and data monitoring needs.
We all know resources are precious, time is the enemy, and results are paramount. Our user-friendly technologies are integrated into all aspects of our clinical development services for improved efficiencies. We have a talented in-house staff that is committed to the professional support of our clients' individual and particular needs and underpins our processes for maximum outcomes.
See videocast on Criterium's Web site: http://www.criteriuminc.com
Through our Phase I-IV trial experience in 20 different therapeutic areas in many regions of the world-including the USA, Central & Eastern Europe, Mexico, South America, Asia-Pacific, India, and South Africa-we have developed best practices to make sure we deliver the highest-quality results on time and on budget for our clients. We stand by this credo for each and every one of our clients.
As part of our full-service capabilities, we believe our unique approach to managing all aspects of the core asset of any clinical study-the data-is just one of the many factors that sets our teams of monitoring experts apart. We recognize the two major areas that most affect the workflow of clinical studies: how quickly the data come in and what happens with that information when it does arrive. To overcome these challenges, we changed the workflow paradigm by paying more attention to these data sets as they become available.
We welcome the opportunity to discuss our many services with you. Let us monitor your data and/or trials and experience the real difference we can create.
At Criterium who we are, what we do, and how we do it are centered on our service reputation: an uncompromising "always deliver" attitude in everything we do.
To mark the occasion we are offering new and existing clients a 15% discount on all services related to the Canadian market.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
